Filing Analysis
Regulation FD Disclosure
Filed Mar 23, 2026
LOW
Pyxis Oncology, Inc. announced its full-year 2025 financial results and provided a corporate update on March 23, 2026. The company also released an updated corporate presentation detailing its current strategic outlook.
Key Facts
- Reported financial results for the full year ended December 31, 2025
- Furnished a press release as Exhibit 99.1
- Made an updated corporate presentation available on the company website (Exhibit 99.2)
- The filing was signed by Jitendra Wadhane, Principal Financial and Accounting Officer
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.